Loading...

World-Class Retina Care. Community-Based Caring.

Dr. Abbey Featured as a Panelist in Retina Times Article on Secondary IOL Placement Surgery

Posted On January 17, 2024 / By / Posted in Blog

Dr. Abbey Featured as a Panelist in Retina Times Article on Secondary IOL Placement Surgery

In the Winter 2023 issue of Retina Times published by the American Society of Retina Specialists (ASRS), Texas Retina Associates’ Ashkan M. Abbey, MD, was featured in an article titled, “Managing the

read more
Posted On November 8, 2023 / By / Posted in Blog

Dr. Abbey Taught a Course at the American Academy of Ophthalmology 2023 Annual Meeting

On November 6, Texas Retina Associates’ Ashkan M. Abbey, MD, taught a continuing medical education (CME) course titled, “Secondary IOL Techniques for Retinal Specialists,” at AAO 2023, the annual meeting of the

read more
Posted On October 12, 2023 / By / Posted in Blog

Getting to Know Diana Laura, MD

Board-certified ophthalmologist and retina specialist Diana M. Laura, MD, joined Texas Retina Associates in September 2022, and cares for patients in our Dallas Main, Rockwall and Wichita Falls offices. She completed her

read more
Posted On October 11, 2023 / By / Posted in Blog

Dr. Abbey Publishes Case Report on Macular Hole Closure with Intravitreal Dexamethasone Implant

In the September 2023 issue of the peer-reviewed medical journal Ophthalmic Surgery, Lasers and Imaging Retina, Texas Retina’s Ashkan Abbey, MD, describes the use of a dexamethasone intravitreal implant to close a

read more
Posted On September 26, 2023 / By / Posted in Blog

Dr. Abbey Publishes Research on Effectiveness of a Long-acting Injectable Steroid for Patients with Cystoid Macular Edema After Vitrectomy

Long-acting injectable steroids have emerged as a new way to treat chronic intraocular inflammation and cystoid macular edema (CME) that reduces the treatment frequency and burden for retina patients. Texas Retina’s Ashkan

read more
Posted On August 8, 2023 / By / Posted in Blog

Dr. Abbey Presented at the American Society of Retina Specialists 2023 Annual Meeting

Texas Retina Associates’ Ashkan M. Abbey, MD, recently presented at the 41st Annual Scientific Meeting of the American Society of Retina Specialists (ASRS) held in Seattle. ASRS is the largest organization of

read more
Posted On May 31, 2023 / By / Posted in Blog

Dr. Abbey Presents Phase 1 DAVIO Clinical Trial Results to the Association for Research in Vision and Ophthalmology

Dr. Abbey presented the results from the Phase 1 DAVIO trial at ARVO 2023, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO). The trial was a first-in-human

read more
Posted On May 23, 2023 / By / Posted in Blog

Dr. Abbey Contributes to Real-world Study of Faricimab for Neovascular Age-related Macular Degeneration

The TRUCKEE study is a real-world, collaborative effort to investigate the efficacy, durability, and safety of a monoclonal antibody treatment called faricimab in patients suffering from neovascular age-related macular degeneration (nAMD) in

read more
Posted On April 25, 2023 / By / Posted in Blog

Dr. Abbey Featured in Retina Times

Texas Retina Associates’ Ashkan Abbey, MD, was featured in the “5 Questions” segment of the latest issue of Retina Today. In the article, he discusses his passion for retina research, what led

read more
Posted On February 6, 2023 / By / Posted in Blog

Dr. Abbey Featured in New Retina Radio Podcast

Texas Retina Associates’ Ashkan M. Abbey, MD, was featured in a recently released New Retina Radio podcast for retina surgeons titled “Tips for Mastering Secondary IOLs.” Dr. Abbey discussed approaches to implanting

read more